Noah Weisleder
Biochemistry, Genetics and Molecular Biology · The Ohio State University
Publications
202
Citations
6,850
Est. group size
~10
Recurring co-author estimate
Active years
27
Publishing since 2000
Noah Weisleder studies how muscle cells maintain and repair their outer membrane and internal structure, focusing on proteins like dysferlin, TRIM72/MG53, and MG29 that are linked to muscle injury, muscular dystrophy, and age-related muscle weakness. His work combines mouse and rat models, cell culture, and molecular biology techniques to understand muscle disease mechanisms and test potential therapies such as fish oil supplements and gene-based approaches. This research is relevant to students interested in muscle biology, membrane repair, neuromuscular disease models, and translational approaches to muscular dystrophy and sarcopenia.
Publication output has fluctuated over the last decade but remained fairly steady overall, with a recent uptick in 2025 following a dip around 2021.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- Hyaluronan 35 prevents endotoxin-mediated dysregulated skeletal muscle proteostasis during ethanol exposure
American Journal of Physiology-Endocrinology and Metabolism · 2026
- Hyaluronan 35 Prevents Endotoxin-mediated Dysregulated Skeletal Muscle Proteostasis During Ethanol Exposure
EngagedScholarship @ Cleveland State University (Cleveland State University) · 2026
- Age- & Muscle-specific Patterns of Dysferlin Expression in Rats Suggest Role in Injury Response
Physiology · 2025
- In Vivo Electroporation of Plasmid DNA into the Skeletal Muscle of Dystrophic Mouse Models
Methods in molecular biology · 2025
- Fish Oil Supplement Mitigates Muscle Injury In Vivo and In Vitro: A Preliminary Report
Nutrients · 2024
- Nanodysferlins support membrane repair and binding to TRIM72/MG53 but do not localize to t-tubules or stabilize Ca2+ signaling
Molecular Therapy — Methods & Clinical Development · 2024
- A Dysferlin Exon 32 Nonsense Mutant Mouse Model Shows Pathological Signs of Dysferlinopathy
Biomedicines · 2023
- Age- & Sex-specific Effects of Trimetazidine Dihydrochloride on Fast- and Slow-muscle Contractility in F344/BN Rats
Physiology · 2023
- P154 The generation of a GNE myopathy patient-derived biobank enables the study of disease-relevant cellular phenotypes across multiple pathogenic variants
Neuromuscular Disorders · 2023
- The C2 domains of dysferlin: roles in membrane localization, Ca<sup>2+</sup> signalling and sarcolemmal repair
The Journal of Physiology · 2022
- Contrasting Effects of Age on Muscle Contractility in Male and Female Rats
The FASEB Journal · 2022
- The Differential Contribution of TRIM72/MG53 Protein Domains in Plasma Membrane Repair
The FASEB Journal · 2022
- Acute Knockdown of MG29 in Mouse Muscle Cells Reveals Signaling Mechanisms Associated with Polyunsaturated Fatty Acid (PUFA) – Implications for Sarcopenia
The FASEB Journal · 2021
- Acute Knockdown of MG29 Alters Skeletal Muscle Cells Differentiation and Leads to Cellular Atrophy
The FASEB Journal · 2020
- Sialic Acid Alterations in Mouse Models of Atrophy and Hypertrophy
The FASEB Journal · 2020
- The FASEB Journal×20
- Physiology×6
- Circulation Research×3
- Neuromuscular Disorders×3
- Annals of the Rheumatic Diseases×3
- Paul T. Martin
Biochemistry, Genetics and Molecular Biology · The Ohio State University
- Renzhi Han
Biochemistry, Genetics and Molecular Biology · Indiana University
- Jill A. Rafael‐Fortney
Biochemistry, Genetics and Molecular Biology · The Ohio State University
- Emily A. Hayes
Biochemistry, Genetics and Molecular Biology · The Ohio State University
- Conner C. Earl
Biochemistry, Genetics and Molecular Biology · Indiana University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile